COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry

In a cohort of severe asthma patients, a small number of COVID-19 cases was found; none resulted in death or a very severe disease course. Use of biologics for severe allergic or severe eosinophilic asthma was not associated with a higher risk of COVID-19. https://bit.ly/3ndZmyD

Detalles Bibliográficos
Autores principales: Hanon, Shane, Brusselle, Guy, Deschampheleire, Maud, Louis, Renaud, Michils, Alain, Peché, Rudi, Pilette, Charles, Rummens, Peter, Schuermans, Daniel, Simonis, Hélène, Vandenplas, Olivier, Schleich, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712385/
https://www.ncbi.nlm.nih.gov/pubmed/33093115
http://dx.doi.org/10.1183/13993003.02857-2020
Descripción
Sumario:In a cohort of severe asthma patients, a small number of COVID-19 cases was found; none resulted in death or a very severe disease course. Use of biologics for severe allergic or severe eosinophilic asthma was not associated with a higher risk of COVID-19. https://bit.ly/3ndZmyD

Ejemplares similares